Companies: 10,795·Total market cap: $144.5T
Inhibikase Therapeutics, Inc.

Inhibikase Therapeutics, Inc.

IKTNASDAQHealthcare● Active
$1.62
$-0.01(-0.61%)
Market Cap$213892870
P/E Ratio—
52W High$2.26
52W Low$1.33
EarningsFinancialsRevenue

Inhibikase Therapeutics, Inc. (IKT) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

IKT · earnings · updated Jun 10, 2026

No earnings history available.

Next Earnings Date

Next earnings date not yet announced.
No earnings history available.
No analyst estimates available for IKT.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: IKT ends December

Inhibikase Therapeutics, Inc. (IKT) reports earnings quarterly as a NASDAQ-listed Biotechnology company.

Each quarter, investors track IKT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IKT revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IKT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

IKT earnings · 3 questions

Inhibikase Therapeutics, Inc.'s next earnings report is expected around TBD. IKT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IKT historically reports after market close (AMC).

IKT earnings datewhen is IKT earningsIKT next earnings datewhen does IKT report earningsIKT earnings calendar

▸ Source: FMP · Inhibikase Therapeutics, Inc. SEC filings · US GAAP · Inhibikase Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026